DIAGNOS Inc. (TSXV: ADK | OTCQB: DGNOF) is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale.
DIAGNOS Inc.
Disclaimer: All stock information on InvestorNews.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.
InvestorNews Features on DIAGNOS Inc.
-
Applying AI for the good of humanity, a tool for early detection of preventable blindness in diabetes patients is here
Is Artificial Intelligence (AI) going to save the world? Likely not if you are a fan of the…